Jeremy R McGarvey1, Norihiro Kondo1, Walter R T Witschey2, Manabu Takebe1, Chikashi Aoki1, Jason A Burdick3, Francis G Spinale4, Joseph H Gorman1, James J Pilla2, Robert C Gorman5. 1. Gorman Cardiovascular Research Group, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Gorman Cardiovascular Research Group, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina. 5. Gorman Cardiovascular Research Group, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: robert.gorman@uphs.upenn.edu.
Abstract
BACKGROUND: There is continued need for therapies which reverse or abate the remodeling process after myocardial infarction (MI). In this study, we evaluate the longitudinal effects of calcium hydroxyapatite microsphere gel on regional strain, global ventricular function, and mitral regurgitation (MR) in a porcine MI model. METHODS: Twenty-five Yorkshire swine were enrolled. Five were dedicated weight-matched controls. Twenty underwent posterolateral infarction by direct ligation of the circumflex artery and its branches. Infarcted animals were randomly divided into the following 4 groups: 1-week treatment; 1-week control; 4-week treatment; and 4-week control. After infarction, animals received either twenty 150 μL calcium hydroxyapatite gel or saline injections within the infarct. At their respective time points, echocardiograms, cardiac magnetic resonance imaging, and tissue were collected for evaluation of MR, regional and global left ventricular function, wall thickness, and collagen content. RESULTS: Global and regional left ventricular functions were depressed in all infarcted subjects at 1 week compared with healthy controls. By 4-weeks post-infarction, global function had significantly improved in the calcium hydroxyapatite group compared with infarcted controls (ejection fraction 0.485 ± 0.019 vs 0.38 ± 0.017, p < 0.01). Similarly, regional borderzone radial contractile strain (16.3% ± 1.5% vs 11.2% ± 1.5%, p = 0.04), MR grade (0.4 ± 0.2 vs 1.2 ± 0.2, p = 0.04), and infarct thickness (7.8 ± 0.5 mm vs 4.5 ± 0.2 mm, p < 0.01) were improved at this time point in the treatment group compared with infarct controls. CONCLUSIONS: Calcium hydroxyapatite injection after MI progressively improves global left ventricular function, borderzone function, and mitral regurgitation. Using novel biomaterials to augment infarct material properties is a viable alternative in the current management of heart failure.
BACKGROUND: There is continued need for therapies which reverse or abate the remodeling process after myocardial infarction (MI). In this study, we evaluate the longitudinal effects of calcium hydroxyapatite microsphere gel on regional strain, global ventricular function, and mitral regurgitation (MR) in a porcine MI model. METHODS: Twenty-five Yorkshire swine were enrolled. Five were dedicated weight-matched controls. Twenty underwent posterolateral infarction by direct ligation of the circumflex artery and its branches. Infarcted animals were randomly divided into the following 4 groups: 1-week treatment; 1-week control; 4-week treatment; and 4-week control. After infarction, animals received either twenty 150 μL calcium hydroxyapatite gel or saline injections within the infarct. At their respective time points, echocardiograms, cardiac magnetic resonance imaging, and tissue were collected for evaluation of MR, regional and global left ventricular function, wall thickness, and collagen content. RESULTS: Global and regional left ventricular functions were depressed in all infarcted subjects at 1 week compared with healthy controls. By 4-weeks post-infarction, global function had significantly improved in the calcium hydroxyapatite group compared with infarcted controls (ejection fraction 0.485 ± 0.019 vs 0.38 ± 0.017, p < 0.01). Similarly, regional borderzone radial contractile strain (16.3% ± 1.5% vs 11.2% ± 1.5%, p = 0.04), MR grade (0.4 ± 0.2 vs 1.2 ± 0.2, p = 0.04), and infarct thickness (7.8 ± 0.5 mm vs 4.5 ± 0.2 mm, p < 0.01) were improved at this time point in the treatment group compared with infarct controls. CONCLUSIONS:Calcium hydroxyapatite injection after MI progressively improves global left ventricular function, borderzone function, and mitral regurgitation. Using novel biomaterials to augment infarct material properties is a viable alternative in the current management of heart failure.
Authors: Frederick H Epstein; Zequan Yang; Wesley D Gilson; Stuart S Berr; Christopher M Kramer; Brent A French Journal: Magn Reson Med Date: 2002-08 Impact factor: 4.668
Authors: Aaron S Blom; Rupak Mukherjee; James J Pilla; Abigail S Lowry; William M Yarbrough; Joseph T Mingoia; Jennifer W Hendrick; Robert E Stroud; Julie E McLean; John Affuso; Robert C Gorman; Joseph H Gorman; Michael A Acker; Francis G Spinale Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: James J Pilla; Aaron S Blom; Joseph H Gorman; Daniel J Brockman; John Affuso; Landi M Parish; Hiroaki Sakamoto; Benjamin M Jackson; Michael A Acker; Robert C Gorman Journal: Ann Thorac Surg Date: 2005-12 Impact factor: 4.330
Authors: Jeremy R McGarvey; Sara Pettaway; James A Shuman; Craig P Novack; Kia N Zellars; Parker D Freels; Randall L Echols; Jason A Burdick; Joseph H Gorman; Robert C Gorman; Francis G Spinale Journal: J Pharmacol Exp Ther Date: 2014-07-14 Impact factor: 4.030
Authors: Yoshiharu Enomoto; Joseph H Gorman; Sina L Moainie; Benjamin M Jackson; Landi M Parish; Theodore Plappert; Ahmad Zeeshan; Martin G St John-Sutton; Robert C Gorman Journal: Ann Thorac Surg Date: 2005-03 Impact factor: 4.330
Authors: James J Pilla; Aaron S Blom; Daniel J Brockman; Frank Bowen; Qing Yuan; Joseph Giammarco; Victor A Ferrari; Joseph H Gorman; Robert C Gorman; Michael A Acker Journal: Circulation Date: 2002-09-24 Impact factor: 29.690
Authors: Benjamin M Jackson; Joseph H Gorman; Sina L Moainie; T Sloane Guy; Navneet Narula; Jagat Narula; Martin G John-Sutton; L Henry Edmunds; Robert C Gorman Journal: J Am Coll Cardiol Date: 2002-09-18 Impact factor: 24.094
Authors: Elena Tous Kichula; Hua Wang; Shauna M Dorsey; Spencer E Szczesny; Dawn M Elliott; Jason A Burdick; Jonathan F Wenk Journal: Ann Biomed Eng Date: 2013-11-23 Impact factor: 3.934
Authors: Brendan P Purcell; David Lobb; Manoj B Charati; Shauna M Dorsey; Ryan J Wade; Kia N Zellars; Heather Doviak; Sara Pettaway; Christina B Logdon; James A Shuman; Parker D Freels; Joseph H Gorman; Robert C Gorman; Francis G Spinale; Jason A Burdick Journal: Nat Mater Date: 2014-03-30 Impact factor: 43.841
Authors: John W MacArthur; Amanda N Steele; Andrew B Goldstone; Jeffrey E Cohen; William Hiesinger; Y Joseph Woo Journal: Curr Treat Options Cardiovasc Med Date: 2017-04
Authors: Christopher B Rodell; Zhang L Zhang; Neville N Dusaj; Yousi Oquendo; Madonna E Lee; Wobbe Bouma; Joseph H Gorman; Jason A Burdick; Robert C Gorman Journal: Semin Thorac Cardiovasc Surg Date: 2019-11-02
Authors: Shauna M Dorsey; Jeremy R McGarvey; Hua Wang; Amir Nikou; Leron Arama; Kevin J Koomalsingh; Norihiro Kondo; Joseph H Gorman; James J Pilla; Robert C Gorman; Jonathan F Wenk; Jason A Burdick Journal: Biomaterials Date: 2015-08-06 Impact factor: 12.479
Authors: Brianna F Moon; Srikant Kamesh Iyer; Eileen Hwuang; Michael P Solomon; Anya T Hall; Rishabh Kumar; Nicholas J Josselyn; Elizabeth M Higbee-Dempsey; Andrew Tsourkas; Akito Imai; Keitaro Okamoto; Yoshiaki Saito; James J Pilla; Joseph H Gorman; Robert C Gorman; Cory Tschabrunn; Samuel J Keeney; Estibaliz Castillero; Giovanni Ferrari; Steffen Jockusch; Felix W Wehrli; Haochang Shou; Victor A Ferrari; Yuchi Han; Avanti Gulhane; Harold Litt; William Matthai; Walter R Witschey Journal: Nat Commun Date: 2020-06-29 Impact factor: 14.919
Authors: Tom Hendriks; Remco A J Schurer; Lawien Al Ali; Ad F M van den Heuvel; Pim van der Harst Journal: Heart Fail Rev Date: 2018-11 Impact factor: 4.214